BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 21670171)

  • 1. A Francisella tularensis locus required for spermine responsiveness is necessary for virulence.
    Russo BC; Horzempa J; O'Dee DM; Schmitt DM; Brown MJ; Carlson PE; Xavier RJ; Nau GJ
    Infect Immun; 2011 Sep; 79(9):3665-76. PubMed ID: 21670171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Francisella tularensis pilin homologs on pilus formation and virulence.
    Ark NM; Mann BJ
    Microb Pathog; 2011 Sep; 51(3):110-20. PubMed ID: 21605655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kdo hydrolase is required for Francisella tularensis virulence and evasion of TLR2-mediated innate immunity.
    Okan NA; Chalabaev S; Kim TH; Fink A; Ross RA; Kasper DL
    mBio; 2013 Feb; 4(1):e00638-12. PubMed ID: 23404403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of TolC Orthologs to
    Kopping EJ; Doyle CR; Sampath V; Thanassi DG
    Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30670554
    [No Abstract]   [Full Text] [Related]  

  • 5. A ΔclpB mutant of Francisella tularensis subspecies holarctica strain, FSC200, is a more effective live vaccine than F. tularensis LVS in a mouse respiratory challenge model of tularemia.
    Golovliov I; Twine SM; Shen H; Sjostedt A; Conlan W
    PLoS One; 2013; 8(11):e78671. PubMed ID: 24236032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Schu S4
    Cunningham AL; Mann BJ; Qin A; Santiago AE; Grassel C; Lipsky M; Vogel SN; Barry EM
    Virulence; 2020 Dec; 11(1):283-294. PubMed ID: 32241221
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential ability of novel attenuated targeted deletion mutants of Francisella tularensis subspecies tularensis strain SCHU S4 to protect mice against aerosol challenge with virulent bacteria: effects of host background and route of immunization.
    Conlan JW; Shen H; Golovliov I; Zingmark C; Oyston PC; Chen W; House RV; Sjöstedt A
    Vaccine; 2010 Feb; 28(7):1824-31. PubMed ID: 20018266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Survival of Virulent Tularemia Pathogens outside a Host in Conditions That Mimic Natural Aquatic Environments.
    Golovliov I; Bäckman S; Granberg M; Salomonsson E; Lundmark E; Näslund J; Busch JD; Birdsell D; Sahl JW; Wagner DM; Johansson A; Forsman M; Thelaus J
    Appl Environ Microbiol; 2021 Feb; 87(6):. PubMed ID: 33397692
    [No Abstract]   [Full Text] [Related]  

  • 9. Contribution of citrulline ureidase to Francisella tularensis strain Schu S4 pathogenesis.
    Mahawar M; Kirimanjeswara GS; Metzger DW; Bakshi CS
    J Bacteriol; 2009 Aug; 191(15):4798-806. PubMed ID: 19502406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Live Attenuated Tularemia Vaccines for Protection Against Respiratory Challenge With Virulent
    Jia Q; Horwitz MA
    Front Cell Infect Microbiol; 2018; 8():154. PubMed ID: 29868510
    [No Abstract]   [Full Text] [Related]  

  • 11. Global transcriptional response to spermine, a component of the intramacrophage environment, reveals regulation of Francisella gene expression through insertion sequence elements.
    Carlson PE; Horzempa J; O'Dee DM; Robinson CM; Neophytou P; Labrinidis A; Nau GJ
    J Bacteriol; 2009 Nov; 191(22):6855-64. PubMed ID: 19749055
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Francisella tularensis subsp. tularensis Schu S4 disulfide bond formation protein B, but not an RND-type efflux pump, is required for virulence.
    Qin A; Scott DW; Mann BJ
    Infect Immun; 2008 Jul; 76(7):3086-92. PubMed ID: 18458069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An
    Golovliov I; Lindgren H; Eneslätt K; Conlan W; Mosnier A; Henry T; Sjöstedt A
    Front Cell Infect Microbiol; 2016; 6():152. PubMed ID: 27933275
    [No Abstract]   [Full Text] [Related]  

  • 14. The D-alanyl-d-alanine carboxypeptidase enzyme is essential for virulence in the Schu S4 strain of Francisella tularensis and a dacD mutant is able to provide protection against a pneumonic challenge.
    Kijek TM; Mou S; Bachert BA; Kuehl KA; Williams JA; Daye SP; Worsham PL; Bozue JA
    Microb Pathog; 2019 Dec; 137():103742. PubMed ID: 31513897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of Francisella tularensis Schu S4 defined mutants as live-attenuated vaccine candidates.
    Santiago AE; Mann BJ; Qin A; Cunningham AL; Cole LE; Grassel C; Vogel SN; Levine MM; Barry EM
    Pathog Dis; 2015 Aug; 73(6):ftv036. PubMed ID: 25986219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions of Francisella tularensis with Alveolar Type II Epithelial Cells and the Murine Respiratory Epithelium.
    Faron M; Fletcher JR; Rasmussen JA; Apicella MA; Jones BD
    PLoS One; 2015; 10(5):e0127458. PubMed ID: 26010977
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Francisella tularensis Schu S4 purine auxotroph is highly attenuated in mice but offers limited protection against homologous intranasal challenge.
    Pechous RD; McCarthy TR; Mohapatra NP; Soni S; Penoske RM; Salzman NH; Frank DW; Gunn JS; Zahrt TC
    PLoS One; 2008 Jun; 3(6):e2487. PubMed ID: 18575611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monophosphoryl Lipid A Enhances Efficacy of a Francisella tularensis LVS-Catanionic Nanoparticle Subunit Vaccine against F. tularensis Schu S4 Challenge by Augmenting both Humoral and Cellular Immunity.
    Richard K; Mann BJ; Qin A; Barry EM; Ernst RK; Vogel SN
    Clin Vaccine Immunol; 2017 Mar; 24(3):. PubMed ID: 28077440
    [No Abstract]   [Full Text] [Related]  

  • 19. Characterization of Inner and Outer Membrane Proteins from
    Post DMB; Slütter B; Schilling B; Chande AT; Rasmussen JA; Jones BD; D'Souza AK; Reinders LM; Harty JT; Gibson BW; Apicella MA
    mBio; 2017 Oct; 8(5):. PubMed ID: 29018123
    [No Abstract]   [Full Text] [Related]  

  • 20. A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine.
    Twine S; Byström M; Chen W; Forsman M; Golovliov I; Johansson A; Kelly J; Lindgren H; Svensson K; Zingmark C; Conlan W; Sjöstedt A
    Infect Immun; 2005 Dec; 73(12):8345-52. PubMed ID: 16299332
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.